Table 2.
Dose | 1 g/m2 (n = 17) | 2 g/m2 (n = 14) | 5 g/m2 (n = 17) |
---|---|---|---|
Infusions | 68 | 56 | 68 |
Gender (F/M) | 5/12 | 7/7 | 13/4 |
SR/IR | 13/4 | 13/1 | –/17 |
Age | 6.17 (2.94) | 3.78 (3.06) | 8.23 (5.25) |
Immunophenotype | Pre B-ALL (17) | Pre B-ALL (13) T-ALL (1) |
Pre-B ALL (16) T-ALL (1) |
SR: Standard risk, IR: Intermediate risk.